Delivra Health Brands Inc
F:U01
Delivra Health Brands Inc
F:U01
Price:
0.0815
EUR
1.24%
Market Closed
Market Cap:
€39m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Delivra Health Brands Inc
F:U01
|
CA |
|
M
|
MorphoSys AG
XMUN:MOR
|
DE |
|
B
|
Bilibili Inc
F:71BA
|
CN |
|
IPG Photonics Corp
NASDAQ:IPGP
|
US |
|
Delivra Health Brands Inc
OTC:DHBUF
|
CA |
|
Q
|
Qurate Retail Inc
SWB:LB3A
|
US |
|
P
|
PennantPark Floating Rate Capital Ltd
F:22P
|
US |
|
C
|
Cidara Therapeutics Inc
F:20D
|
US |
|
Perella Weinberg Partners
NASDAQ:PWP
|
US |
|
A
|
African Rainbow Capital Investments Ltd
JSE:AIL
|
MU |
|
S
|
Sega Sammy Holdings Inc
XBER:RYU
|
JP |
|
M
|
Medtronic PLC
DUS:2M6
|
IE |
|
L
|
Luminar Technologies Inc
F:9FS
|
US |
|
Ipsos SA
OTC:IPSOF
|
FR |
Wall St Price Targets
U01 Price Targets Summary
Delivra Health Brands Inc
Delivra Health Brands Inc
Wall Street analysts forecast U01 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for U01 is 0.4895 EUR with a low forecast of 0.4847 EUR and a high forecast of 0.5039 EUR.
Lowest Forecast
Price Target
0.4847
EUR
495% Upside
Average Forecast
Price Target
0.4895
EUR
501% Upside
Highest Forecast
Price Target
0.5039
EUR
518% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is U01's stock price target?
Price Target
0.4895
EUR
0.4895
EUR
According to Wall Street analysts, the average 1-year price target for U01 is 0.4895 EUR with a low forecast of 0.4847 EUR and a high forecast of 0.5039 EUR.
What is the Revenue forecast for Delivra Health Brands Inc?
Projected CAGR
14%
14%
The compound annual growth rate for Revenue over the next 2 years is 14%.
